1991 - 1999: Medical School, University of Cologne
07/2007: Habilitation in Pediatrics, Faculty of Medicine, University of Cologne
06/2002: M.D., Medical School, University of Cologne, Summa cum Laude: “Charakterisierung der Antikörpergene humaner CD5-positiver B-Zellen und Plasmazellen der Darmschleimhaut mittels Einzelzell-PCR” (Supervisor: Ralf Küppers, PhD; Department I for Internal Medicine, University of Cologne, Head: Volker Diehl, M.D.)
05/1999: Graduation from Medical School, University of Cologne, Summa cum Laude
2016 - present: W2 Professorship, Head of the Department of Experimental Pediatric Oncology, University of Cologne
2015 - 2016: Research period at the Max-Planck-Institute for Metabolism Research, Cologne (Laboratory Prof. Dr. J. Brüning)
2014 - present: Deputy head of the Department of Pediatric Oncology, University Hospital of Cologne
2013: Appointment as Professor for Pediatrics, University of Cologne
2009 - present: Consultant pediatric oncologist, University Hospital of Cologne
2006: Board examination pediatrics
2005 - 2009: Resident physician, Department of Pediatric Oncology, University Hospital of Cologne
2001 - 2015: Independent research group leader, Department of Pediatric Oncology, University Hospital of Cologne
1999 - 2005: Resident physician, Department of Pediatrics, University Hospital of Cologne
2018: Adalbert-Czerny Award, German Society of Pediatrics and Adolescent Medicine (DGKJ)
2018: Elected member of the ANRA Steering Committee
2017: Board of Directors of the international Massive Analysis and Quality Control (MAQC) Society
2017: Head of the national Biobank Neuroblastoma
2017: Principal Investigator at the Center for Molecular Medicine Cologne (CMMC), University of Cologne
2016: Gerhard-Domagk-Award 2016, Gerhard Domagk-Stiftung, Münster
2015: Board member of the Center for Integrated Oncology (CIO) Köln-Bonn
2014: Member of the Trial Committee of the Registry Individualized Therapy for Relapsed Malignancies in Childhood (INFORM)
2014: Elected member of the international Advances in Neuroblastoma Research Association (ANRA) Advisory Board
2011: Member of the International Neuroblastoma Response Criteria (INPC) and the International Neuroblastoma Risk Group (INRG) consortia
2011: Member of the national Neuroblastoma Trial Committee
1994 - 1998: Scholar of the Studienstiftung des Deutschen Volkes
Professor (W2) and Head of the Department of Experimental Pediatric Oncology
University Hospital of Cologne
Department of Experimental Pediatric Oncology
Center for Molecular Medicine Cologne (CMMC)